Maithilee Mistry to join Abbott India from Sanofi Consumer Healthcare India as CFO
Advertisement
Mumbai: Abbott India has announced the appointment of Maithilee Mistry as the Chief Financial Officer of the Company with effect from May 6, 2025.
On her appointment as Chief Financial Officer, Mistry shall also be the Key Managerial Personnel of the Company effective the same date.
"We hereby inform you that, upon recommendation of the Nomination and Remuneration Committee and the Audit Committee, the Board of Directors at its Meeting held today i.e., April 18, 2025, approved the appointment of Ms. Maithilee Mistry as the Chief Financial Officer of the Company with effect from May 6, 2025," the Company stated in a BSE filing.
Maithilee Mistry is a seasoned finance professional having an extensive work experience spanning more than 25 years, having held leadership roles in various Multinational companies.
Previously, Maithilee held a role of CFO for Sanofi Consumer Healthcare India Limited. Prior to that, she worked with Dow chemical in USA as global Funding Director, responsible for all aspects of corporate funding and banking relations. Before relocating to USA, she was Finance Director for Dow Chemical, India subcontinent region. Maithilee has also served as Board member in various companies including a public listed entity and other joint ventures in India. Before Joining Dow, she has also held leadership positions with Omya and Cognis, European multinational companies, leading teams in India and Southwest Asia with responsibilities for Finance, HR, Legal and IT.
She is a qualified Chartered Accountant who started her career with Deloitte (India) as a member of statutory audit team.
Headquartered in Mumbai, Abbott India Limited, a publicly listed company and a subsidiary of Abbott Laboratories The Company offers medicines in multiple therapeutic categories such as women's health, gastroenterology, cardiology, metabolic disorders and primary care.
Abbott India Limited is part of Abbott's global pharmaceutical business in India.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.